Lake Street analyst Ben Klieve initiated coverage of Vital Farms (VITL) with a Buy rating and $22 price target. Vital Farms "represents a tentpole institutional investment" given that next-generation animal protein company Vital has consistent 25%-plus volume growth and stable, premium pricing versus legacy producers like Cal-Maine (CALM) with flat volume growth and "significant commodity pricing exposure," the analyst tells investors.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VITL:
- Vital Farms releases three ESG goals its aiming to hit in next five years
- Vital Farms Sets Three ESG Goals and Celebrates Progress Towards Improving the Lives of People, Animals, and the Planet Through Food in 2023 Impact Report
- Vital Farms sees FY23 revenue more than $450M, consensus $440.77M
- Vital Farms sees FY23 revenue $450M +, consensus $440.77M.
- Vital Farms reports Q4 EPS 4c, consensus 4c